Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
COSTS AND EXPENSES:        
Research and development $ 10,314 $ 5,217 $ 26,014 $ 12,842
General and administrative 2,966 2,217 8,746 5,810
Total operating expenses 13,280 7,434 34,760 18,652
Operating loss (13,280) (7,434) (34,760) (18,652)
Interest income, net 30 15 66 25
NET LOSS $ (13,250) $ (7,419) $ (34,694) $ (18,627)
Net loss per common share, basic and diluted (in dollars per share) $ (0.72) $ (0.71) $ (2.15) $ (1.92)
Weighted average common shares outstanding, basic and diluted (in shares) 18,423,816 10,496,504 16,103,382 9,719,142